MarketResearchReports.com: The Market Value for Monoclonal Antibodies ... SBWire (press release) Lewes, DE -- (SBWIRE) -- 12/31/2013 -- The market value for monoclonal antibodies (mAbs) in colorectal cancer treatment will experience a moderate increase from $3.7 billion in 2012 to $5.5 billion by 2019, at a Compound Annual Growth Rate (CAGR) of ... |
